Compositions and methods for the modulation of the...

Details Compositions and methods for the modulation of the... Compositions and methods for the modulation of the...

2011-06-14

2011-06-14

Epps-Smith, Janet L (Department: 1633)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S023100, C536S024300, C536S024310, C536S024500

Reexamination Certificate

active

07960355

ABSTRACT:
Antisense oligonucleotide compositions which specifically hybridize with nucleic acids encoding B7 proteins, and use of these compositions for inhibiting expression of B7 mRNA.

REFERENCES:
patent: 4689320 (1987-08-01), Kaji
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 5004810 (1991-04-01), Draper
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5087617 (1992-02-01), Smith
patent: 5098890 (1992-03-01), Gewirtz et al.
patent: 5135917 (1992-08-01), Burch
patent: 5138045 (1992-08-01), Cook et al.
patent: 5166195 (1992-11-01), Ecker
patent: 5194428 (1993-03-01), Agrawal et al.
patent: 5218105 (1993-06-01), Cook et al.
patent: 5242906 (1993-09-01), Pagano et al.
patent: 5264423 (1993-11-01), Cohen et al.
patent: 5276019 (1994-01-01), Cohen et al.
patent: 5286717 (1994-02-01), Cohen et al.
patent: 5434131 (1995-07-01), Linsley et al.
patent: 5459255 (1995-10-01), Cook et al.
patent: 5512438 (1996-04-01), Ecker
patent: 5514788 (1996-05-01), Bennett et al.
patent: 5539082 (1996-07-01), Nielsen et al.
patent: 5667998 (1997-09-01), Dougherty et al.
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5877021 (1999-03-01), Stinchcomb et al.
patent: 5883082 (1999-03-01), Bennett et al.
patent: 5942607 (1999-08-01), Freeman et al.
patent: 5998148 (1999-12-01), Bennett et al.
patent: 6077833 (2000-06-01), Bennett et al.
patent: 6319906 (2001-11-01), Bennett et al.
patent: 6582908 (2003-06-01), Fodor et al.
patent: 7115580 (2006-10-01), Bennett et al.
patent: 2001/0053519 (2001-12-01), Fodor et al.
patent: 2003/0228597 (2003-12-01), Cowsert et al.
patent: 0 643 077 (1993-09-01), None
patent: 0 600 591 (2003-05-01), None
patent: WO 92/20823 (1992-11-01), None
patent: WO 93/24134 (1993-12-01), None
patent: WO 94/17773 (1994-08-01), None
patent: WO 95/03408 (1995-02-01), None
patent: WO 95/05464 (1995-02-01), None
patent: WO 95/06738 (1995-03-01), None
patent: WO 95/07358 (1995-03-01), None
patent: WO 95/22619 (1995-08-01), None
patent: WO 95/32734 (1995-12-01), None
patent: WO 95/34320 (1995-12-01), None
patent: WO 96/11279 (1996-04-01), None
patent: WO 96/15780 (1996-05-01), None
patent: WO 96/18736 (1996-06-01), None
patent: WO 99/01579 (1999-01-01), None
patent: WO 00/74687 (2000-12-01), None
patent: WO 00/074687 (2000-12-01), None
patent: WO 0074687 (2000-12-01), None
patent: WO0074687 (2000-12-01), None
patent: WO 03/083089 (2003-10-01), None
Vester et al. Biochemistry, 2004, 43 (42), 13233-13241.
Kurreck et al. (Nucleic Acids Research, 2002, vol. 30, No. 9, pp. 1911-1918).
Alberts, B. et al.,Molecular Biology of the Cell(1983) Garland Publishing, Inc., New York, pp. 411-415.
Allison, J. P., “CD28-B7 interactions in T-cell activation,”Curr. Opin. Immunol. (1994) 6:414-419.
Allison, J. P. et al., “The Yin and Yang of T Cell Costimulation,”Science(1995) 270:932-3.
Azuma, M. et al., “B70 antigen is a second ligand for CTLA-4 and CD28,”Nature(1993) 366:76-79.
Berkow et al., eds.,The Merck Manual of Diagnosis and Therapy(1987) 15thEd., Rahway, NJ, pp. 302-336 and 2516-2522.
Borriello F. et al., “Characterization of the Murine B7-1 Genomic Locus Reveals an Additional Exon Encoding an Alternative Cytoplasmic Domain and a Chromosomal Location of Chromosome 16, Band B5,”J. Immunol. (1994) 153:5038-5048.
Borriello, F. et al., “Differential Expression of Alternate mB7-2 Transcripts,”J. Immunol. (1995) 155:5490-5497.
Brigstock, D. R. et al., “Species-Specific High Molecular Weight Forms of Basic Fibroblast Growth Factor,”Growth Factors(1990) 4:45-52.
Charachon, G. et al., “Phosphorothioate Analogues of (2′-5′)(A)4: Agonist and Antagonist Activities in Intact Cells,”Biochem. (1990) 29(10):2550-2556.
Chen, C. et al., “Monoclonal Antibody 2D10 Recognizes a Novel T Cell Costimulatory Molecule on Activated Murine B Lymphocytes,”J. Immunol. (1994) 152:2105-2114.
Chen, C. et al., “Molecular Cloning and Expression of Early T Cell Costimulatory Molecule-1 and Its Characterization as B7-2 Molecule,”J. Immunol. (1994) 152:4929-4936.
Cook, P. D., “Medicinal Chemistry Strategies for Antisense Research,”Antisense Research and Applications(1993) CRC Press, Boca Raton, pp. 171-172.
Crooke, S. T. et al., “Pharmacokinetic Properties of Several Novel Oligonucleotide Analogs in mice,”J. Pharmacol. Exp. Ther. (1996) 277(2):923-937.
De Virgilio, C. et al., “Cloning and Disruption of a Gene Required for Growth on Acetate but not on Ethanol: the Acetyl-Coenzyme A Synthetase Gene ofSaccharomyces cerevisiae,” Yeast(1992) 8:1043-1051.
Dulbecco, R. et al., “Plaque Production by the Polyoma Virus,”Virol. (1959) 8:396-397.
Freeman, G. J. et al. “B7, A New Member of the Ig Superfamily with Unique Expression on Activated and Neoplastic B Cells,”J. Immunol. (1989) 143(8):2714-2722.
Freeman, G. J. et al., “Structure, Expression, and T Cell Costimulatory Activity of the Murine Homologue of the Human B Lymphocyte Activation Antigen B7,”J. Exp. Med. (1991) 174:625-631.
Freeman, G. J. et al., “Cloning of B7-2: A CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation,”Science(1993) 262:909-911.
French, T. J. et al., “Expression of Two Related Nonstructural Proteins of Bluetongue Virus (BTV) Type 10 in Insect Cells by a Recombinant Baculovrus: Production of Polyclonal Ascitic Fluid and Characterization of the Gene Product in BTV-Infected BHK Cells,”J. Virol. (1989) 63(8):3270-3278.
Gao, J. et al., “Cloning and Characterization of a Mouse Gene with Homology to the Human von Hippel-Lindau Disease Tumor Suppressor Gene: Implications for the Potential Organization of the Human von Hippel-Lindau Diesease Gene,”Cancer Res. (1995) 55:743-747.
Gebeyehu, G. et al., “Novel biotinylated nucleotide—analogs for labeling and colorimetric detection of DNA,”Nucleic Acids Res. (1987) 15(11):4513-4534.
Gelbert, L. M. et al., “Analysis of GPT Activity in Mammalian Cells with a Chromosomally Integrated Shuttle Vector Containing AlteredgptGenes,”Somat. Cell. Mol. Genet. (1990) 16(2):173-184.
Gold, L. et al., “Translation Initiation,”Escherichia coli and Salmonella typhimuium: Cellular and Molecular Biology(1987) 2:1302-1307.
Hakim, F. T. et al., “Acute Graft-Versus-Host Reaction Can Be Aborted by Blockade of Costimulatory Molcules,”J. Immunol. (1995) 155:1757-1766.
Harlan, D. M. et al., “Mice expression both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness,”Proc. Natl. Acad. Sci. USA(1994) 91:3137-3141.
Hathcock, K. S. et al., “Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation,”Science(1993) 262:905-907.
Inobe, M. et al., “The Role of the B7-la Molecule, an Altneratively Spliced Form of Murine B7-1 (CD80), on T Cell Activation,”J Immunol. (1996) 157:582-588.
Jellis, C. L. et al., “Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86),”Immunogenet. (1995) 42:85-89.
June, C. H. et al., “The B7 and CD28 receptor families,”Immunol. Today(1994) 15(7):321-331.
Kabanov, A. V. et al., “A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells,”FEBS Lett. (1990) 259(2):327-330.
Kanagasundaram, V. et al., “Isolation of characterization of the gene encoding gluconolactonase fromZymomonas mobilis,” Biochint. Biophs. Acta(1992) 1171:198-200.
Kornberg, A.,DNA Replication(1974) W. H. Freeman & Co., San Francisco, pp. 75-77.
Lenschow, D. J. et al., “Long-Term Survival of Xenogenic Pancreatic Islet Grafts Induced by CTLA4Ig,”Science(1992) 257:789-792.
Lenschow, D. J. e

Affiliated with

Also associated with

Rating

Compositions and methods for the modulation of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for the modulation of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the modulation of the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2745461